Jian Qiu

Title: Jian Qiu: Innovator in Pharmaceutical Compounds

Introduction

Jian Qiu is a notable inventor based in the United States, recognized for his contributions to the field of pharmaceutical compounds. Despite having no patents to his name, his work has significantly impacted the development of innovative therapeutic agents.

Latest Patents

Jian Qiu's latest inventions include "Substituted Quinoline Compounds As S-Nitrosoglutathione Reductase Inhibitors." This invention focuses on quinoline compounds that serve as inhibitors for S-nitrosoglutathione reductase (GSNOR). The pharmaceutical compositions derived from these compounds are aimed at providing new treatment options. Another significant contribution is in the area of "Selective Estrogen Receptor Modulators." This disclosure introduces a new class of selective estrogen receptor modulators (SERMs) and identifies a previously unknown membrane-associated estrogen receptor. The methods for making and using these SERMs are also included, along with pharmaceutical formulations of the novel compounds.

Career Highlights

Throughout his career, Jian Qiu has worked with reputable organizations such as Laurel Therapeutics Ltd. and Oregon Health & Science University. His experience in these institutions has allowed him to collaborate on various innovative projects and contribute to advancements in pharmaceutical research.

Collaborations

Jian Qiu has collaborated with notable colleagues, including Xicheng David Sun and Adam Stout. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and innovation in the field.

Conclusion

Jian Qiu's work in pharmaceutical compounds showcases his dedication to innovation and research. His contributions, particularly in the development of S-Nitrosoglutathione reductase inhibitors and selective estrogen receptor modulators, highlight his role as an influential figure in the pharmaceutical industry.